Report cover image

Global Type 1 Diabetes Market and Competitive Landscape – 2017

Publisher Fore Pharma
Published Aug 17, 2017
SKU # FPCI15450492

Description

Global Type 1 Diabetes Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Type 1 Diabetes Market and Competitive Landscape – 2017, provides comprehensive insights into Type 1 Diabetes pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Type 1 Diabetes market size and drug sales. This research also provides insights into Type 1 Diabetes epidemiology and late stage pipeline.
The report is classified into twelve sections – Type 1 Diabetes overview with definitions, symptoms, etiology, diagnosis, treatment options; Type 1 Diabetes pipeline insights covering late stage clinical trials pipeline; Type 1 Diabetes prevalence trends by countries; Type 1 Diabetes market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:
  • Type 1 Diabetes pipeline: Find out the drugs in clinical trials for Type 1 Diabetes by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Type 1 Diabetes epidemiology: Find out the prevalence of Type 1 Diabetes by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Type 1 Diabetes products: Identify key products marketed and prescribed for Type 1 Diabetes by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Type 1 Diabetes market size: Find out the market size for Type 1 Diabetes drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Type 1 Diabetes drug sales: Find out the sales of Type 1 Diabetes drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Type 1 Diabetes drugs sales forecast: Sales forecast for Type 1 Diabetes drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Type 1 Diabetes market share analysis: Find out the market shares of Type 1 Diabetes drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Type 1 Diabetes drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Type 1 Diabetes market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Type 1 Diabetes market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents

1. Type 1 Diabetes: Disease Overview
1.1. Type 1 Diabetes Symptoms
1.2. Type 1 Diabetes Etiology
1.3. Type 1 Diabetes Diagnosis
1.4. Type 1 Diabetes Treatment Options
2. Type 1 Diabetes Pipeline Insights
2.1. Type 1 Diabetes Phase 3 Clinical Trials
2.2. Type 1 Diabetes Phase 2 Clinical Trials
2.3. Type 1 Diabetes Phase 1 Clinical Trials
3. Type 1 Diabetes Epidemiology Analysis
4. US Type 1 Diabetes Market Insights
4.1. Marketed Products for Type 1 Diabetes in US
4.2. US Type 1 Diabetes Market Size & Forecast
4.3. US Type 1 Diabetes Product Sales Forecast
4.4. US Type 1 Diabetes Market Share Analysis
5. Germany Type 1 Diabetes Market Insights
5.1. Marketed Products for Type 1 Diabetes in Germany
5.2. Germany Type 1 Diabetes Market Size & Forecast
5.3. Germany Type 1 Diabetes Product Sales Forecast
5.4. Germany Type 1 Diabetes Market Share Analysis
6. France Type 1 Diabetes Market Insights
6.1. Marketed Products for Type 1 Diabetes in France
6.2. France Type 1 Diabetes Market Size & Forecast
6.3. France Type 1 Diabetes Product Sales Forecast
6.4. France Type 1 Diabetes Market Share Analysis
7. Italy Type 1 Diabetes Market Insights
7.1. Marketed Products for Type 1 Diabetes in Italy
7.2. Italy Type 1 Diabetes Market Size & Forecast
7.3. Italy Type 1 Diabetes Product Sales Forecast
7.4. Italy Type 1 Diabetes Market Share Analysis
8. Spain Type 1 Diabetes Market Insights
8.1. Marketed Products for Type 1 Diabetes in Spain
8.2. Spain Type 1 Diabetes Market Size & Forecast
8.3. Spain Type 1 Diabetes Product Sales Forecast
8.4. Spain Type 1 Diabetes Market Share Analysis
9. UK Type 1 Diabetes Market Insights
9.1. Marketed Products for Type 1 Diabetes in UK
9.2. UK Type 1 Diabetes Market Size & Forecast
9.3. UK Type 1 Diabetes Product Sales Forecast
9.4. UK Type 1 Diabetes Market Share Analysis
10. Europe Type 1 Diabetes Market Insights
10.1. Europe Type 1 Diabetes Market Size & Forecast
10.2. Europe Type 1 Diabetes Product Sales Forecast
10.3. Europe Type 1 Diabetes Market Share Analysis
11. Japan Type 1 Diabetes Market Insights
11.1. Marketed Products for Type 1 Diabetes in Japan
11.2. Japan Type 1 Diabetes Market Size & Forecast
11.3. Japan Type 1 Diabetes Product Sales Forecast
11.4. Japan Type 1 Diabetes Market Share Analysis
12. Global Type 1 Diabetes Market Insights
12.1. Global Type 1 Diabetes Market Size & Forecast
12.2. Global Type 1 Diabetes Product Sales Forecast
12.3. Global Type 1 Diabetes Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Type 1 Diabetes Phase 3 Clinical Trials, Global, 2017
Table 2: Type 1 Diabetes Phase 2 Clinical Trials, Global, 2017
Table 3: Type 1 Diabetes Phase 1 Clinical Trials, Global, 2017
Table 4: Type 1 Diabetes Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Type 1 Diabetes in US, 2017
Table 6: US Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 8: US Type 1 Diabetes Market Trends, 2012 - 2021
Table 9: Marketed Products for Type 1 Diabetes in Germany, 2017
Table 10: Germany Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 12: Germany Type 1 Diabetes Market Trends, 2012 - 2021
Table 13: Marketed Products for Type 1 Diabetes in France, 2017
Table 14: France Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 16: France Type 1 Diabetes Market Trends, 2012 - 2021
Table 17: Marketed Products for Type 1 Diabetes in Italy, 2017
Table 18: Italy Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 20: Italy Type 1 Diabetes Market Trends, 2012 - 2021
Table 21: Marketed Products for Type 1 Diabetes in Spain, 2017
Table 22: Spain Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 24: Spain Type 1 Diabetes Market Trends, 2012 - 2021
Table 25: Marketed Products for Type 1 Diabetes in UK, 2017
Table 26: UK Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 28: UK Type 1 Diabetes Market Trends, 2012 - 2021
Table 29: Europe Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Type 1 Diabetes in Japan, 2017
Table 32: Japan Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Table 34: Japan Type 1 Diabetes Market Trends, 2012 - 2021
Table 35: Global Type 1 Diabetes Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Type 1 Diabetes Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Type 1 Diabetes Pipeline by Phase (%), Global, 2017
Figure 2: Type 1 Diabetes Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 4: US Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 5: US Type 1 Diabetes Market Share by Products (%), 2016
Figure 6: US Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 7: Germany Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 8: Germany Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 9: Germany Type 1 Diabetes Market Share by Products (%), 2016
Figure 10: Germany Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 11: France Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 12: France Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 13: France Type 1 Diabetes Market Share by Products (%), 2016
Figure 14: France Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 15: Italy Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 16: Italy Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 17: Italy Type 1 Diabetes Market Share by Products (%), 2016
Figure 18: Italy Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 19: Spain Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 20: Spain Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 21: Spain Type 1 Diabetes Market Share by Products (%), 2016
Figure 22: Spain Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 23: UK Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 24: UK Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 25: UK Type 1 Diabetes Market Share by Products (%), 2016
Figure 26: UK Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 27: Europe Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 28: Europe Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 29: Europe Type 1 Diabetes Market Share by Products (%), 2016
Figure 30: Europe Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 31: Japan Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 32: Japan Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 33: Japan Type 1 Diabetes Market Share by Products (%), 2016
Figure 34: Japan Type 1 Diabetes Market - Future Market Share (%), 2021
Figure 35: Global Type 1 Diabetes Market Size ($mn), 2012 - 2021
Figure 36: Global Type 1 Diabetes Product Sales ($mn), 2012 - 2021
Figure 37: Global Type 1 Diabetes Market Share by Products (%), 2016
Figure 38: Global Type 1 Diabetes Market - Future Market Share (%), 2021

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us